ESMO scientific and educational resources on this topic
Recent medwireNews and resources from conferences are for ESMO Members only.
Cancer Immunology and Immunotherapy
Latest ESMO videos
Featured medwireNews
AEGEAN Updates Add Support For Perioperative Durvalumab In NSCLC Except For EGFR-Mutated
TROPiCS-02 Update Confirms Sacituzumab Govitecan Survival Advantage
Final KEYNOTE-826 Survival Findings Support Pembrolizumab Use
Perioperative Pembrolizumab Strategy Improves Resectable NSCLC Outcomes
Unresectable Desmoplastic Melanoma Patients ‘Exceptional Responders’ To Pembrolizumab
E-Learning
ESMO E-Learning: First Line Immunotherapy for Oesophageal and Gastric Cancer as New Standard of Care
ESMO E-Learning: Metastatic Melanoma Treatment
ESMO E-Learning: Immunotherapy Strategies for Colorectal Cancer
Factsheets on Biomarkers
Tumour Mutational Load: ESMO Biomarker Factsheet
Meeting resources
ESMO Course
ESMO Preceptorship on Immuno-Oncology 2023: Zurich
Zurich
ESMO Course
ESMO Preceptorship on Immuno-Oncology 2022: Zurich, December
Zurich
ESMO Course
ESMO Preceptorship on Immuno-Oncology 2022: Singapore
Singapore
ESMO Congress
ESMO Immuno-Oncology Congress 2022
Geneva
ESMO Course
ESMO Preceptorship on Immuno-Oncology 2022: Zurich, June
Zurich